Abstract
Although the current literature is limited, available data suggest that 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) imaging improves the evaluation of patients with recurrent pancreatic carcinoma and cholangiocarcinoma. There is evidence that PET/CT is particularly useful in the setting of elevated tumor markers and negative or equivocal CT findings. This article reviews the nature of these carcinomas in the post-therapy setting and describes the strengths and limitations of PET/CT when used for monitoring recurrence.
Original language | English |
---|---|
Pages (from-to) | 463-471 |
Number of pages | 9 |
Journal | Abdominal Imaging |
Volume | 36 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2011 |
Keywords
- Cholangiocarcinoma
- Oncology
- PET/CT
- Pancreatic carcinoma
- Recurrence
- Restaging